{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:12:34Z","timestamp":1790727154675,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.cgh.2012.08.038","type":"journal-article","created":{"date-parts":[[2012,9,14]],"date-time":"2012-09-14T15:08:17Z","timestamp":1347635297000},"page":"1402-1409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Low-Dose Hydroxychloroquine Is as Effective as Phlebotomy in Treatment of Patients With Porphyria Cutanea Tarda"],"prefix":"10.1016","volume":"10","author":[{"given":"Ashwani K.","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Kormos\u2013Hallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaithamanithi M.","family":"Sadagoparamanujam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Daniel H.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2012.08.038_bib1","series-title":"Porphyrin handbook, part II; 14","first-page":"67","article-title":"Porphyria cutanea tarda and related disorders (chapter 88)","author":"Elder","year":"2003"},{"key":"10.1016\/j.cgh.2012.08.038_bib2","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1073\/pnas.0700547104","article-title":"A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda","volume":"104","author":"Phillips","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cgh.2012.08.038_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.0954-6820.1970.tb08003.x","article-title":"Iron storage in porphyria cutanea tarda","volume":"12","author":"Lundvall","year":"1970","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.cgh.2012.08.038_bib4","first-page":"248","article-title":"Iron overload in porphyria cutanea tarda","volume":"84","author":"Sampietro","year":"1999","journal-title":"Haematologica"},{"key":"10.1016\/j.cgh.2012.08.038_bib5","first-page":"2020","article-title":"[Porphyria cutanea tarda]","volume":"162","author":"Bygum","year":"2000","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/j.cgh.2012.08.038_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0741-8329(03)00127-7","article-title":"Iron as a co-morbid factor in nonhemochromatotic liver disease","volume":"30","author":"Bonkovsky","year":"2003","journal-title":"Alcohol"},{"key":"10.1016\/j.cgh.2012.08.038_bib7","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1002\/hep.21903","article-title":"Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda","volume":"46","author":"Gorman","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2012.08.038_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2340\/00015555-0472","article-title":"Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study","volume":"88","author":"Dereure","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2012.08.038_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.cgh.2009.11.017","article-title":"Associations among behavior-related susceptibility factors in porphyria cutanea tarda","volume":"8","author":"Jalil","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib10","first-page":"253","article-title":"Treatment of porphyria cutanea tarda by phlebotomy","volume":"14","author":"Ippen","year":"1977","journal-title":"Semin Hematol"},{"key":"10.1016\/j.cgh.2012.08.038_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM196812122792402","article-title":"Porphyria cutanea tarda","volume":"279","author":"Epstein","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.0954-6820.1971.tb04337.x","article-title":"The effect of phlebotomy therapy in porphyria cutanea tarda","volume":"189","author":"Lundvall","year":"1971","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.cgh.2012.08.038_bib13","first-page":"124","article-title":"The effect of venesection therapy on liver tissue in porphyria cutanea tarda","volume":"20","author":"Chlumsk\u00fd","year":"1973","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"key":"10.1016\/j.cgh.2012.08.038_bib14","first-page":"1","article-title":"The treatment of porphyria cutanea tarda by venesection","volume":"43","author":"Ramsay","year":"1974","journal-title":"Q J Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00000441-198301000-00001","article-title":"Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda","volume":"285","author":"Di Padova","year":"1983","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cgh.2012.08.038_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000249600","article-title":"Phlebotomy treatment in porphyria cutanea tarda combined with beta-thalassaemia","volume":"169","author":"Adjarov","year":"1984","journal-title":"Dermatologica"},{"key":"10.1016\/j.cgh.2012.08.038_bib17","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1440-0960.1988.tb01216.x","article-title":"Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection","volume":"29","author":"Ratnaike","year":"1988","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib18","first-page":"36","article-title":"Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda","volume":"107","author":"Rocchi","year":"1986","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2340\/0001555561346350","article-title":"A comparative study of the results of phlebotomy therapy and low-dose chloroquine treatment in porphyria cutanea tarda","volume":"61","author":"Malina","year":"1981","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.cgh.2012.08.038_bib20","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1136\/bmj.1.5445.1281","article-title":"Effects of chloroquine on patients with cutaneous porphyria of the \u201csymptomatic\u201d type","volume":"1","author":"Sweeney","year":"1965","journal-title":"Br Med J"},{"key":"10.1016\/j.cgh.2012.08.038_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0009-9120(86)80064-9","article-title":"Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases","volume":"19","author":"Sweeney","year":"1986","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cgh.2012.08.038_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00005792-196645060-00024","article-title":"Effect of chloroquine on hepatic uroporphyrin metabolism in patients with porphyria cutanea tarda","volume":"45","author":"Felsher","year":"1966","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.cgh.2012.08.038_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1001\/jama.1973.03220050023005","article-title":"The therapeutic effect of chloroquine","volume":"223","author":"Kowertz","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2012.08.038_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2133.1974.tb06367.x","article-title":"Treatment of porphyria cutanea tarda with chloroquine","volume":"90","author":"Kordac","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib25","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJM197704212961627","article-title":"Chloroquine in the treatment of porphyria cutanea tarda","volume":"296","author":"Kordac","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2133.1983.tb01062.x","article-title":"Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda","volume":"108","author":"Cainelli","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib27","first-page":"286","article-title":"A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients","volume":"1","author":"Marchesi","year":"1984","journal-title":"Photo Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.1984.tb06632.x","article-title":"Low-dose oral chloroquine in the treatment of porphyria cutanea tarda","volume":"111","author":"Ashton","year":"1984","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib29","first-page":"223","article-title":"[Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine]","volume":"65","author":"Seubert","year":"1990","journal-title":"Z Hautkr"},{"key":"10.1016\/j.cgh.2012.08.038_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0923-1811(94)90092-2","article-title":"Low-dose oral chloroquine in patients with porphyria cutanea tarda and low-moderate iron overload","volume":"7","author":"Valls","year":"1994","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.cgh.2012.08.038_bib31","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000211340","article-title":"Treatment of porphyria cutanea tarda by the effect of chloroquine on the liver","volume":"8","author":"Freesemann","year":"1995","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.cgh.2012.08.038_bib32","first-page":"456","article-title":"[Treatment of porphyria cutanea tarda with chloroquine and its effect on associated liver disease: retrospective analysis]","volume":"124","author":"Wolff","year":"1996","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.cgh.2012.08.038_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/1523-1747.ep12676478","article-title":"The molecular basis of the action of chloroquine in porphyria cutanea tarda","volume":"61","author":"Scholnick","year":"1973","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00414107","article-title":"Influence of chloroquine on the porphyrin metabolism","volume":"277","author":"Goerz","year":"1985","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.cgh.2012.08.038_bib35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archderm.1980.01640340057016","article-title":"Hydroxychloroquine treatment of porphyria cutanea tarda","volume":"116","author":"Malkinson","year":"1980","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF00414107","article-title":"Influence of chloroquine on the porphyrin metabolism","volume":"277","author":"Goerz","year":"1985","journal-title":"Arch Dermatol Res"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2012.08.038_bib37","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1177\/0961203396005001171","article-title":"Ophthalmologic considerations in using antimalarials in the United States","volume":"5","author":"Rynes","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.cgh.2012.08.038_bib38","first-page":"362","article-title":"Direct spectrofluorometry of diluted erythrocytes and plasma: a rapid diagnostic method in primary and secondary porphyrinemias","volume":"87","author":"Poh-Fitzpatrick","year":"1976","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1023\/A:1013746828074","article-title":"Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency","volume":"47","author":"Egger","year":"2002","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2012.08.038_bib40","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2119\/molmed.2010.00130","article-title":"CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda","volume":"17","author":"Wickliffe","year":"2011","journal-title":"Mol Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archderm.139.3.309","article-title":"Hemochromatosis (HFE) gene mutations and response to chloroquine in porphyria cutanea tarda","volume":"139","author":"St\u00f6lzel","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib42","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.cgh.2012.08.038_bib43","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I","article-title":"Interval estimation for the difference between independent proportions: comparison of eleven methods","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib44","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1067\/mlc.2000.111024","article-title":"Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda","volume":"136","author":"Bulaj","year":"2000","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib46","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2133.1972.tb00316.x","article-title":"Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria","volume":"87","author":"Taljaard","year":"1972","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib47","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0002-9343(70)80022-5","article-title":"Biochemical effects of chloroquine therapy in porphyria cutanea tarda","volume":"49","author":"Vogler","year":"1970","journal-title":"Am J Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib48","first-page":"119","article-title":"Chloroquine in treatment of porphyria cutanea tarda","volume":"100","author":"Wennersten","year":"1982","journal-title":"Acta Dermatovener"},{"key":"10.1016\/j.cgh.2012.08.038_bib49","first-page":"953","article-title":"Long-term effect of high-dose, short-course chloroquine therapy on porphyria cutanea tarda","volume":"65","author":"Tsega","year":"1987","journal-title":"Q J Med"},{"key":"10.1016\/j.cgh.2012.08.038_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0190-9622(92)70090-3","article-title":"High-dose hydroxychloroquine treatment of porphyria cutanea tarda","volume":"26","author":"Petersen","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.cgh.2012.08.038_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2340\/00015555-0260","article-title":"Porphyria cutanea tarda: effects and risk factors for hepatotoxicity from high-dose chloroquine treatment","volume":"87","author":"Rossmann-Ringdahl","year":"2007","journal-title":"Acta Derm Venereol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651201052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154235651201052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:09:53Z","timestamp":1761541793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154235651201052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S154235651201052X"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2012.08.038","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-Dose Hydroxychloroquine Is as Effective as Phlebotomy in Treatment of Patients With Porphyria Cutanea Tarda","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2012.08.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}